Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 1
2007 2
2008 2
2009 1
2014 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Phase II study of irinotecan combined with carboplatin in previously untreated non-small-cell lung cancer.
Fukuda M, Oka M, Soda H, Kinoshita A, Fukuda M, Nagashima S, Kuba M, Takatani H, Tsurutani J, Nakamura Y, Kasai T, Inoue Y, Soejima Y, Kohno S; Nagasaki Thoracic Oncology Group. Fukuda M, et al. Cancer Chemother Pharmacol. 2004 Dec;54(6):573-7. doi: 10.1007/s00280-004-0805-2. Epub 2004 Sep 10. Cancer Chemother Pharmacol. 2004. PMID: 15365766 Clinical Trial.
A phase I study of amrubicin and carboplatin for previously untreated patients with extensive-disease small cell lung cancer.
Fukuda M, Nakamura Y, Kasai T, Nagashima S, Nakatomi K, Doi S, Nakano H, Takatani H, Fukuda M, Kinoshita A, Soda H, Tsukamoto K, Oka M, Kohno S; Nagasaki Thoracic Oncology Group. Fukuda M, et al. J Thorac Oncol. 2009 Jun;4(6):741-5. doi: 10.1097/JTO.0b013e3181a52946. J Thorac Oncol. 2009. PMID: 19404211 Free article. Clinical Trial.
A phase II study of amrubicin and carboplatin for previously untreated patients with extensive-disease small cell lung cancer.
Ikeda T, Fukuda M, Nakamura Y, Kinoshita A, Senju H, Nakano H, Kitazaki T, Ogawara D, Taniguchi H, Motoshima K, Yamaguchi H, Nakatomi K, Shimada M, Nagashima S, Tsukamoto K, Kohno S; Nagasaki Thoracic Oncology Group. Ikeda T, et al. Cancer Chemother Pharmacol. 2014 Sep;74(3):497-502. doi: 10.1007/s00280-014-2527-4. Epub 2014 Jul 18. Cancer Chemother Pharmacol. 2014. PMID: 25034978 Free article. Clinical Trial.
Phase I study of vinorelbine and irinotecan in previously untreated patients with advanced non-small cell lung cancer.
Tomonaga N, Nakamura Y, Soda H, Nagashima S, Nakano H, Kinoshita A, Fukuda M, Fukuda M, Takatani H, Soejima Y, Oka M, Kohno S; Nagasaki Thoracic Oncology Group. Tomonaga N, et al. Cancer Chemother Pharmacol. 2008 Jun;62(1):43-9. doi: 10.1007/s00280-007-0571-z. Epub 2007 Aug 24. Cancer Chemother Pharmacol. 2008. PMID: 17717667 Clinical Trial.